Compare LFVN & BCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LFVN | BCIC |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.0M | 86.9M |
| IPO Year | 1996 | 2006 |
| Metric | LFVN | BCIC |
|---|---|---|
| Price | $6.43 | $7.73 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $11.00 | $9.00 |
| AVG Volume (30 Days) | ★ 61.7K | 50.4K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | 3.56% | ★ 14.14% |
| EPS Growth | 226.09 | ★ 262.50 |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $203,204,000.00 | N/A |
| Revenue This Year | N/A | $0.00 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.63 | ★ N/A |
| Revenue Growth | ★ 1.86 | N/A |
| 52 Week Low | $3.90 | $6.70 |
| 52 Week High | $14.28 | $13.50 |
| Indicator | LFVN | BCIC |
|---|---|---|
| Relative Strength Index (RSI) | 48.54 | 66.88 |
| Support Level | $6.05 | $7.02 |
| Resistance Level | $6.51 | $7.80 |
| Average True Range (ATR) | 0.28 | 0.20 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 37.18 | 83.88 |
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
BCP Investment Corp is an externally managed, non-diversified closed-end investment company. The company invests in secured term loans, bonds or notes and mezzanine debt in privately-held middle market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt and selected equity investments in privately-held middle market companies.